Your search for smoking cessation returned 9 results

According to a study in the journal Nicotine and Tobacco Research, the smoking cessation treatment varenicline is more effective for women in short and immediate outcomes compared to men, but is equally effective for both with longer outcomes.

One year after the national drug store chain CVS/pharmacy ceased tobacco sales in its stores, parent company CVS Health is reporting positive data on its tobacco cessation efforts and public health overall based on a decrease in the number of cigarette purchases in the United States.

Rather than increase the rate at which Americans successfully quit smoking, varenicline appears to have had no significant impact on the rates of smoking and the effectiveness is short-lived compared to other cessation aides.

A study appearing in Neuroscience and Biobehavioral Reviews suggests that pharmacokinetics play a significant role in the risk of abuse and misuse associated with varying drugs, from nicotine to cocaine.

A new study in The Lancet Psychiatry suggests that smoking tobacco is associated with an increased risk of developing psychosis.

Regular aspirin use is associated with a slower progression of early emphysema on computed tomography (CT) scans over the course of 10 years, according to research presented the 2015 American Thoracic Society International Conference.

Electronic cigarettes (e-cigarettes) may actually hinder, not help, cigarette smokers when it comes to quitting.

The Food and Drug Administration (FDA) has announced that the labeling for varenicline (Chantix; Pfizer) has been updated to include information on changes to alcohol tolerance and risk of seizures associated with use of the drug.

A new study in the Journal of Psychopharmacology has found that use of psychedelic drugs such as lysergic acid diethylamide (LSD) and psilocybin (magic mushrooms) does not increase a person’s risk of developing mental health problems such as depression and suicidal thoughts.